LSM1 homolog, mRNA degradation associated pseudogene 2 (LSM1P2)

LSM1 homolog, mRNA degradation associated pseudogene 2 (LSM1P2) is a pseudogene that shares sequence homology with LSM1, a gene encoding a component of the Lsm1-7-Pat1 complex involved in mRNA degradation and regulation of histone mRNA decay in eukaryotes[3][1]. Unlike its functional counterpart, LSM1P2 does not encode a functional protein and is not currently known to have an active biological role beyond possible regulatory effects typical of pseudogenes[3][2]. Pseudogenes can sometimes regulate gene expression at the RNA level—by acting as decoys for microRNAs or RNA-binding proteins—but no specific regulatory or clinical function has been demonstrated for LSM1P2 specifically[2]. There is no evidence indicating that LSM1P2 acts as a therapeutic target, is associated directly with human disease, or that it interacts with any approved drugs[3][2]. Key facts: - LSM1P2 is *not* an active gene or protein target; it is a pseudogene[3]. - It should not be considered a molecular target for drug development or biomarker purposes. - The parent gene, LSM1, functions in mRNA degradation and genome stability in yeast and humans but this does not apply to its pseudogene LSM1P2[1][4]. Summary: LSM1P2 is a noncoding pseudogene with sequence similarity to LSM1. It is not a receptor, enzyme, or other druggable protein and has no demonstrated direct role in disease, therapeutics, or as a biomarker. Its only function—if any—would be regulatory at the RNA level, consistent with general features of pseudogenes, but this has not been demonstrated for LSM1P2 specifically[2][3].

Other names

LSM1, U6 small nuclear RNA associated pseudogene 2LSM1P2